Digital tools for supporting women with postpartum depression

Introduction

Women’s health has been a key focus of many recent technological advances. One of the most common health challenges faced by nearly 1 in 7 women worldwide is postpartum depression (PPD) after childbirth. While traditional treatments—such as therapy, medication, and peer support—remain essential, technology is playing an increasingly important role in bridging gaps in access, privacy, and immediate care. A growing number of devices and mobile apps are being developed to support new mothers.

Digital Tools for Supporting Women with Postpartum Depression

Various mobile apps have been developed for providing professional support while facilitating accessible therapy and providing mental health resources, where certain apps are catered specifically for women’s health. For example, ‘Maven Clinic’ is a women’s health app offering virtual appointments with therapists, psychiatrists, and postpartum specialists. There are also various meditation and mindfulness apps that can help manage stress, anxiety, and insomnia, which is common in the postpartum period. Some developments have also been made in artificial intelligence (AI) powered chatbots that may use cognitive behavioural therapy (CBT) techniques to help mothers track mood patterns and reframe negative thinking. Such apps may particularly be helpful for new mothers that struggle to find time for therapy while caring for a newborn, and they provide flexibility, anonymity, and immediate access to coping tools.

Some apps also help women track patterns in mood and symptoms, that can generate accurate reports for sharing with healthcare providers. There are further apps providing peer support platforms, which helps elevate isolation for new mothers.

AI has played a major role in providing targeted digital therapeutics for postpartum care. Such AI powered apps include Woebot and Bloom (offering therapist-designed programs focusing on maternal anxiety and depression).

In addition to mobile apps, wearable devices including smart monitors also indirectly support mental health in the postpartum stage by monitoring sleep, stress, or physical activity. The ‘Oura Ring’ tracks sleep cycles, heart rate, and stress levels, which are factors that can significantly affect postpartum depression. Apple Watch & Fitbit offer guided breathing, reminders for movement, and mood-tracking integrations. Wearable devices may provide real-time feedback, helping mothers stay mindful of their physical and mental health.

Patents in of Digital Therapeutics

The digital therapeutics patent landscape for postpartum depression (PPD) is still evolving with ongoing regulatory and efficacy research, while specific patent activity has had a focus on software-based treatments incorporating techniques like Cognitive Behavioural Therapy (CBT) and leveraging adaptive algorithms for personalized interventions delivered via mobile apps, AI, or VR. Developers aim to provide non-pharmaceutical alternatives, addressing the accessibility gap for women with PPD. A notable patent-pending solution has been developed by Curio- the MamaLift and MamaLift Plus apps, which provide prenatal and postpartum support through self-guided therapy, tracking tools, and access to live therapists.

A significant driver for innovation is the desire to offer non-drug alternatives to manage PPD, particularly given the shortage of mental health professionals. Many patents in this field are focused on technology-based approaches, such as mobile applications for software designed for delivering cognitive behavioural therapy, which may use AI-driven tools for personized interventions or adaptive treatment. Some patents also cover app features that promote social connection and engagement, leveraging peer support and information sharing, which are important aspects of peripartum mental health management. The developing patent landscape also involves designing digital therapeutics to be used adjunctively with traditional, clinician-managed care.

For businesses looking to develop technologies in this sector, patent protection may be useful for protecting novel digital methods for delivering a specific psychological technique (e.g., mindfulness, guided imagery), or for protecting innovative features to keep patients or users engaged with the digital therapeutics. Technologies for seamless adjustments and improvements in the therapeutic experience, or adjacency with infant devices (e.g. linking infant sleep data to maternal health recommendations) or linking therapeutic solutions with perinatal specific timelines may also be of particular interest for patent protection.

Conclusion

Devices and apps cannot replace professional care, but they can play a vital role in supporting women through postpartum depression. By combining digital tools with clinical treatment and community support, a more accessible and compassionate postpartum care system can be created. As with any other technological advances, patent protection can offer key incentive for innovations and investment in new and improved tools for supporting women’s health.